Integrated Short-Term Palliative Rehabilitation in Incurable Cancer

Launched by KING'S COLLEGE LONDON · Aug 2, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether adding a special type of rehabilitation, called palliative rehabilitation, to regular care can improve the quality of life for patients with incurable solid cancers, such as lung, colorectal, breast, or prostate cancer. The goal is to see if this approach helps patients feel better and manage their symptoms more effectively. The trial is currently recruiting participants aged 18 and older, who have a diagnosis of incurable solid cancer and can participate in assessments.

If you or someone you know is interested in this trial, participants will need to be able to understand and give consent for the study. However, those with blood cancers or who are currently receiving certain types of rehabilitation are not eligible. Throughout the trial, participants can expect to receive support and care aimed at enhancing their well-being, alongside their usual treatment. This study hopes to provide valuable insights into how additional rehabilitation can help improve the lives of those facing serious health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18 years or older.
• • Diagnosis of incurable solid cancer: lung, colorectal, breast, prostate or other, irrespective of timing in relation to any oncology or palliative care treatments
• • Eastern Cooperative Oncology Group performance status 2-3
• • Able to provide informed consent and complete trial assessments in available languages.
• Exclusion Criteria:
• • Blood cancers: Leukaemia, Lymphoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder (MPD), Multiple Myeloma.
• • Currently receiving specialist rehabilitation\* for their cancer or co-morbidity-related dysfunction, or received within the two weeks prior to consent.
• • Clinician rated prognosis of less than 3 months.